---
figid: PMC9545784__FCP-36-790-g002
pmcid: PMC9545784
image_filename: FCP-36-790-g002.jpg
figure_link: /pmc/articles/PMC9545784/figure/fcp12782-fig-0002/
number: FIGURE 2
figure_title: ''
caption: Hematoxylin and eosin (H&E) staining shows the effect of EDB on morphological
  changes in the mice hippocampus CA1 area. (a) Sham group. (b) CIRI group. (c) CIRI + EDB
  group. (d) KO sham group. (e) KO CIRI group. (f) KO CIRI + EDB group (magnification,
  ×400)
article_title: Edaravone dexborneol protects cerebral ischemia reperfusion injury
  through activating Nrf2/HO‐1 signaling pathway in mice.
citation: Lili Xu, et al. Fundam Clin Pharmacol. 2022 Oct;36(5):790-800.
year: '2022'

doi: 10.1111/fcp.12782
journal_title: Fundamental & Clinical Pharmacology
journal_nlm_ta: Fundam Clin Pharmacol
publisher_name: John Wiley and Sons Inc.

keywords:
- cerebral ischemia reperfusion injury
- Edaravone dexborneol
- inflammation
- NADPH oxidase 2
- Nrf2/HO‐1 pathway

---
